Five years of hard work has paid off for the team at Pelvalon. Last year the FDA had designated the company’s de novo application a Priority Review and today the team received word that FDA has approved the device. Women suffering from loss of bowel control now have a viable, safe solution to their debilitating condition. Congratulations to the Pelvalon team!
Congratulations to the Vaxess team for winning the prestigious Verizon start-up award! The team took home the top prize in the transportation category for their plans to create a soluble, silk-stabilized vaccine that can be shipped without refrigeration, and extend the global reach and access to vaccine products.